IQVIA Holdings (MEX:IQV) Cyclically Adjusted Revenue per Share: MXN1,245.99 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:IQV IQVIA Holdings Inc MEX:IQV
75 GF Score
Price MXN4,047.88
GF Value MXN3,815.66
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is IQVIA Holdings Cyclically Adjusted Revenue per Share?

IQVIA Holdings MEX:IQV -1.94% 75 Cyclically Adjusted Revenue per Share is MXN1,245.99 as of Jun. 2026. GuruFocus rates MEX:IQV with a GF Score™ of 75/100 and a GF Value™ of MXN3,815.66 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

IQVIA Holdings's adjusted revenue per share for the three months ended in Jun. 2026 was MXN455.572. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN1,245.99 for the trailing ten years ended in Jun. 2026.

During the past 12 months, IQVIA Holdings's average Cyclically Adjusted Revenue Growth Rate was 8.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of IQVIA Holdings was 8.90% per year. The lowest was 7.50% per year. And the median was 8.20% per year.

As of today (2026-08-03), IQVIA Holdings's current stock price is MXN4047.88. IQVIA Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN1,245.99. IQVIA Holdings's Cyclically Adjusted PS Ratio of today is 3.25.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of IQVIA Holdings was 5.17. The lowest was 1.88. And the median was 3.21.


IQVIA Holdings  (MEX:IQV) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

IQVIA Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4047.88/1245.99
=3.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of IQVIA Holdings was 5.17. The lowest was 1.88. And the median was 3.21.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


IQVIA Holdings Cyclically Adjusted Revenue per Share Related Terms


IQVIA Holdings Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for IQVIA Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings Cyclically Adjusted Revenue per Share Chart

IQVIA Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,121.52 1,198.89 1,120.14 1,466.57 1,365.84

IQVIA Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,413.49 1,372.09 1,365.84 1,359.37 1,245.99

MEX:IQV vs WAT, NTRA, A: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, IQVIA Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Cyclically Adjusted PS Ratio falls into.


MEX:IQV
75GF Score
IQVIA Holdings Inc MEX:IQV
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IQVIA Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IQVIA Holdings's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=455.572/333.9520*333.9520
=455.572

Current CPI (Jun. 2026) = 333.9520.

IQVIA Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 238.822 241.428 330.347
201612 199.251 241.432 275.607
201703 189.172 243.801 259.123
201706 191.493 244.955 261.066
201709 204.351 246.819 276.492
201712 231.145 246.524 313.119
201803 219.639 249.554 293.920
201806 240.306 251.989 318.469
201809 234.627 252.439 310.388
201812 258.720 251.233 343.904
201903 258.127 254.202 339.108
201906 262.375 256.143 342.077
201909 274.701 256.759 357.288
201912 277.297 256.974 360.363
202003 329.973 258.115 426.923
202006 304.819 257.797 394.865
202009 315.780 260.280 405.161
202012 335.913 260.474 430.672
202103 357.534 264.877 450.772
202106 351.138 271.696 431.597
202109 357.019 274.310 434.644
202112 382.507 278.802 458.171
202203 367.334 287.504 426.679
202206 372.778 296.311 420.133
202209 378.298 296.808 425.640
202212 386.714 296.797 435.125
202303 349.031 301.836 386.169
202306 342.327 305.109 374.688
202309 350.819 307.789 380.640
202312 355.861 306.746 387.423
202403 336.518 312.332 359.812
202406 379.126 314.175 402.992
202409 416.468 315.301 441.103
202412 456.817 315.605 483.373
202503 441.570 319.799 461.112
202506 436.703 322.561 452.125
202509 438.039 324.800 450.382
202512 457.641 324.054 471.619
202603 440.835 330.213 445.827
202606 455.572 333.952 455.572

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN1,245.99 mean?
IQVIA Holdings (MEX:IQV) has a Cyclically Adjusted Revenue per Share of MXN1,245.99 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on IQVIA Holdings and its competitors.
Is IQVIA Holdings' Cyclically Adjusted Revenue per Share too high?
IQVIA Holdings' current Cyclically Adjusted Revenue per Share is MXN1,245.99. Overall, IQVIA Holdings has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IQVIA Holdings' Cyclically Adjusted Revenue per Share compare to WAT and NTRA?
IQVIA Holdings' Cyclically Adjusted Revenue per Share of MXN1,245.99 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on IQVIA Holdings and its competitors. IQVIA Holdings's current Cyclically Adjusted Revenue per Share is MXN1,245.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IQVIA Holdings stock overvalued right now?
Based on GuruFocus' analysis, IQVIA Holdings (MEX:IQV) is currently considered Fairly Valued. The stock's GF Value™ is MXN3,815.66, compared to a current price of MXN4,047.88 — trading 6.1% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN1,245.99. IQVIA Holdings' overall GF Score™ is 75/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For IQVIA Holdings (MEX:IQV), the current Cyclically Adjusted Revenue per Share is MXN1,245.99 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IQVIA Holdings (MEX:IQV) Overvalued in 2026?

Based on GuruFocus' analysis, IQVIA Holdings stock appears to be overvalued. The current stock price of MXN4,047.88 is trading 6.1% above its estimated GF Value™ of MXN3,815.66. GuruFocus considers IQVIA Holdings to be Fairly Valued.

Key valuation signals for MEX:IQV:

  • Cyclically Adjusted Revenue per Share: MXN1,245.99
  • GF Value™: MXN3,815.66 vs. price of MXN4,047.88 (6.1% above fair value)
  • GF Score™: 75/100 with 8 warning signs

No single metric tells the full story. See the MEX:IQV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IQVIA Holdings Business Description

Address 2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
75GF Score

Get the complete analysis for MEX:IQV

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN4,047.88
Price
MXN3,815.66
GF Value